CoChat

Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study

Reig, Anna, Álvarez-Navascués, Carmen, Vergara, Mercedes, Gómez-Domínguez, Elena, Gallego-Moya, Adolfo, Pérez-Medrano, Indhira M., Fábrega, Emilio, Hernández-Guerra, Manuel, Berenguer, Marina, Estevez, Pamela, Arencibia, Ana, Morillas, Rosa M., Horta, Diana, Albillos, Agustín, Casado, Marta, De la Cruz, Gema, Fernandez-Bonilla, Eva, Molina, Esther, Hijona, Lander, Diago, Moises, Fernández-Rodriguez, Conrado M., González-Santiago, Jesús M., Sala, Margarita, Gómez-Camarero, Judith, Romero-Gomez, Manuel, Suárez, Francisco, Vargas, Victor, Ferre-Aracil, Carlos, Andrade, Raúl J., Chahri, Nadia, Parés, Albert · 2021 · American Journal of Gastroenterology
Cited by 35

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Obeticholic acid (OCA) and fibrates therapy results in biochemical improvement in placebo-controlled trials in patients with primary biliary cholangitis and insufficient response to ursodeoxycholic acid. There is scarce information outside of clinical trials. Therefore, we have assessed the effectiveness and adverse events of these treatments. METHODS: Data from patients included in the ColHai registry treated with OCA, fibrates, or both were recorded during a year, as well as adverse events and treatment discontinuation. RESULTS: Eighty-six patients were treated with OCA, 250 with fibrates (81% bezafibrate; 19% fenofibrate), and 15 with OCA plus fibrates. OCA group had baseline significantly higher alkaline phosphatase (ALP) (P = 0.01) and lower platelets (P = 0.03) than fibrates. Both treatments significantly decreased ALP, gamma-glutamyl transferase (GGT), and transaminases and improved Globe score. Albumin and immunoglobulin type M improved in the fibrates group. ALP decrease was higher under fibrates, whereas alanine aminotransferase decline was higher under OCA. Although baseline transaminases and GGT were higher in patients with OCA plus fibrates, significant ALP, GGT, alanine aminotransferase, and Globe score improvement were observed during triple therapy. Adverse events were reported in 14.7% of patients (21.3% OCA; 17.6% fenofibrate; 10.7% bezafibrate), mainly pruritus (10.1% with OCA). Discontinuation was more frequent in fenofibrate treatment mainly because of intolerance or adverse events. DISCUSSION: Second-line therapy with OCA or fibrates improves hepatic biochemistry and the GLOBE score in primary biliary cholangitis patients with suboptimal response to ursodeoxycholic acid. Simultaneous treatment with OCA and fibrates improved ALP as well.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14309/ajg.0000000000001343

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 35

Metadata

Authors
Reig, A., Álvarez-Navascués, C., Vergara, M., Gómez-Domínguez, E., Gallego-Moya, A., Pérez-Medrano, I. M., Fábrega, E., Hernández-Guerra, M., Berenguer, M., Estevez, P., Arencibia, A., Morillas, R. M., Horta, D., Albillos, A., Casado, M., De la Cruz, G., Fernandez-Bonilla, E., Molina, E., Hijona, L., Diago, M., Fernández-Rodriguez, C. M., González-Santiago, J. M., Sala, M., Gómez-Camarero, J., Romero-Gomez, M., Suárez, F., Vargas, V., Ferre-Aracil, C., Andrade, R. J., Chahri, N., & Parés, A.
Venue
American Journal of Gastroenterology
Published
2021-06-23
Volume
116
Issue
11
Pages
2250-2257
ISSN
  • 0002-9270 (ISSN-L)
  • 1572-0241
OpenAlex
W3174888168
Cited by
35
References
13
FWCI
2.23
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study. https://app.cochat.ai/papers/10.14309/ajg.0000000000001343
The paper
Reig, A., Álvarez-Navascués, C., Vergara, M., Gómez-Domínguez, E., Gallego-Moya, A., Pérez-Medrano, I. M., Fábrega, E., Hernández-Guerra, M., Berenguer, M., Estevez, P., Arencibia, A., Morillas, R. M., Horta, D., Albillos, A., Casado, M., De la Cruz, G., Fernandez-Bonilla, E., Molina, E., Hijona, L., . . . Parés, A. (2021). Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study. American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000001343

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.